Carvedilol-loaded Mucoadhesive Buccal Tablets: Influence of Various Mucoadhesive Polymers on Drug Release Behavior

References

1. 1.↵
   Summary Sheet for Carvedilol— Midland Therapeutic Review and Advisory Committee (MTRAC) guidance, SS04/06, 3 2004.
2. 2.↵
   1. Morgan T.

   Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet. 1994, 26 ( 5), 335– 346.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Harris D.,
   2. Robinson J. R.

   Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992, 81 ( 1), 1– 10.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Chien Y. W.

   Novel Drug Delivery Systems, 2nd ed.; New York: Marcel Dekker, Inc.; 1992, pp 183.
5. 5.↵
   1. Singh B.,
   2. Ahuja N.

   Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride. Optimisation of bioadhesion, dissolution, and diffusion parameters. Drug Dev. Ind. Pharm. 2002, 28 ( 4), 431– 442.

   OpenUrlPubMed
6. 6.↵
   1. Cappello B.,
   2. De Rosa G.,
   3. Giannini L.,
   4. La Rotonda M. I.,
   5. Mensitieri G.,
   6. Miro A.,
   7. Quaglia F.,
   8. Russo R.

   Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Int. J. Pharm. 2006, 319 ( 1–2), 63– 70.

   OpenUrlPubMed
7. 7.↵
   1. Miro A.,
   2. Quaglia F.,
   3. Giannini L.,
   4. Cappello B.,
   5. La Rotonda M. I.

   Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. Curr. Drug Del. 2006, 3 ( 4), 373– 378.

   OpenUrl
8. 8.↵
   1. Liebermann H. A.,
   2. Rieger M. M.,
   3. Banker G. S.

   1. Ofner C. M., III,
   2. Schnaare R. L.,
   3. Schwartz J. B.

   Oral Aqueous Suspensions. In Pharmaceutical Dosage Forms: Disperse Systems, 2nd ed.; Liebermann H. A., Rieger M. M., Banker G. S. Eds. New York: Marcel Dekker Inc., 1996; Vol. 2, pp 149– 181.

   OpenUrl
9. 9.↵
   1. Mitchell K.,
   2. Ford J. L.,
   3. Armstrong D. J.,
   4. Elliott P. N. C.,
   5. Hogan J. E.,
   6. Rostron C.

   The influence of drugs on the properties of gels and swelling characteristics of matrices containing methyl cellulose or hydroxypropylmethlylcellulose. Int. J. Pharm. 1993, 100, 165– 173.

   OpenUrl
10. 10.↵
    1. Tur K. M.,
    2. Ch'ng H.-S.

    Evaluation of possible mechanism(s) of bioadhesion. Int. J. Pharm. 1998, 160 ( 1), 61– 74.

    OpenUrl
11. 11.↵
    United States Pharmacopoeia XXII. Rockville, MD: US Pharmacopoeial Convention Inc., 2000.
12. 12.↵
    Indian Pharmacopoeia. Ministry of Health, Government of India, New Delhi, 1996.
13. 13.↵
    1. Aggarwal V.,
    2. Mishra B.

    Design, development and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm. 1999, 25 ( 6), 701– 709.

    OpenUrlPubMed
14. 14.↵
    1. Vishnu V. Y.,
    2. Chandrasekhar K.,
    3. Ramesh G.,
    4. Madhusudan Rao Y.

    Development of mucoadhesive patches for buccal administration of carvedilol. Curr. Drug Deliv. 2007, 4 ( 1), 27– 39.

    OpenUrlPubMed
15. 15.↵
    1. Parodi B.,
    2. Russo E.,
    3. Caviglioli G.,
    4. Cafaggi S.,
    5. Bignardi G.

    Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev. Ind. Pharm. 1996, 22 ( 5), 445– 450.

    OpenUrl
16. 16.
    1. Gupta A.,
    2. Garg S.,
    3. Khar R. K.

    Measurement of bioadhesive strength of mucoadhesive buccal tablets: design of an in vitro assembly. Indian Drugs 1993, 30, 152– 155.

    OpenUrl
17. 17.
    1. El-Kamel A.,
    2. Sokar M.,
    3. Naggar V.,
    4. Gamal S. A.

    Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSciTech 2002, 4, Article 4.
18. 18.↵
    1. Perioli L.,
    2. Ambrogi V.,
    3. Rubini D.,
    4. Giovagnoli S.,
    5. Ricci M.,
    6. Blasi P.,
    7. Rossi C.

    Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J. Controlled Release 2004, 95 ( 3), 521– 533.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Bottenberg P.,
    2. Cleymaet R.,
    3. de Muynck C.,
    4. Remon J. P.,
    5. Coomans D.,
    6. Michotte Y.,
    7. Slop D.

    Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J. Pharm. Pharmacol. 1991, 43 ( 7), 457– 464.

    OpenUrlPubMed
20. 20.↵
    1. Dinsheet S. P.,
    2. Agarwal Y.,
    3. Ahuja A.

    Mucoadhesive buccal tablets of Hydralazine Hcl. Ind J. Pharm. Sci. 1997, 59 ( 3), 135– 141.

    OpenUrl
21. 21.↵
    1. Jain N. K.

    1. Devarajan P. V.,
    2. Gandhi A. S.

    In Vitro and In Vivo Models for Oral Transmucosal Drug Delivery. In Advances in Controlled and Novel Drug Delivery; Jain N. K. Ed.; New Delhi, India: CBS Publishers and Distributors, 2001; pp 71– 73.
22. 22.↵
    1. Lund W.

    Accelerated Chemical Stability Tests. In The Pharmaceutical Codex; London, UK: The Pharmaceutical Press, 1994; pp. 301.
23. 23.↵
    1. Lachman L.,
    2. Liebermann H. A.,
    3. Kanig J. L.

    1. Banker G. S.,
    2. Anderson N. R.

    Tablets. In The Theory and Practice of Industrial Pharmacy; 3rd ed.; Lachman L., Liebermann H. A., Kanig J. L. Eds.; Bombay, India: Varghese Publishing House, 1992; p 300.
24. 24.↵
    1. Jug M.,
    2. Bećirević-Laćan M.

    Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci. 2004, 21 ( 21943), 251– 260.

    OpenUrlPubMed